Keywords: fda, oks, first, arv, triple, therapy, ldcs

US FDA OKs first ARV triple therapy for LDCs

Article | 31 January 2005

Print This

The US Food and Drug Administration has announced the tentative approval of a co-packaged antiretroviral drug regimen manufactured by Aspen ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in